Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

Saved in:
Bibliographic Details
Title: Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Authors: Couturier, Marie-Anne1 (AUTHOR), Thomas, Xavier2 (AUTHOR), Raffoux, Emmanuel3 (AUTHOR), Huguet, Françoise4 (AUTHOR), Berthon, Céline5 (AUTHOR), Simand, Célestine6 (AUTHOR), Gallego-Hernanz, Maria-Pilar7 (AUTHOR), Hicheri, Yosr8 (AUTHOR), Hunault Berger, Mathilde9 (AUTHOR), Saillard, Colombe10 (AUTHOR), Leguay, Thibaut11 (AUTHOR), Loiseau, Clémence12 (AUTHOR), Béné, Marie-Christine13 (AUTHOR), Chevallier, Patrice14 (AUTHOR)
Source: Leukemia & Lymphoma. Mar2021, Vol. 62 Issue 3, p620-629. 10p.
Database: Academic Search Ultimate
Description
ISSN:10428194
DOI:10.1080/10428194.2020.1844198